Literature DB >> 19268493

Receptor and substrate interactions of clostridial neurotoxins.

Axel T Brunger1, Andreas Rummel.   

Abstract

The high potency of clostridial neurotoxins relies predominantly on their neurospecific binding and specific hydrolysis of SNARE proteins. Their multi-step mode of mechanism can be ascribed to their multi-domain three-dimensional structure. The C-terminal H(CC)-domain interacts subsequently with complex polysialo-gangliosides such as GT1b and a synaptic vesicle protein receptor via two neighbouring binding sites, resulting in highly specific uptake of the neurotoxins at synapses of cholinergic motoneurons. After its translocation the enzymatically active light chain specifically hydrolyses specific SNARE proteins, preventing SNARE complex assembly and thereby blocking exocytosis of neurotransmitter.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19268493      PMCID: PMC2756235          DOI: 10.1016/j.toxicon.2008.12.027

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  121 in total

Review 1.  Synaptotagmin: a Ca(2+) sensor that triggers exocytosis?

Authors:  Edwin R Chapman
Journal:  Nat Rev Mol Cell Biol       Date:  2002-07       Impact factor: 94.444

2.  Identification of the amino acid residues rendering TI-VAMP insensitive toward botulinum neurotoxin B.

Authors:  Stefan Sikorra; Tina Henke; Subramanyam Swaminathan; Thierry Galli; Thomas Binz
Journal:  J Mol Biol       Date:  2006-01-18       Impact factor: 5.469

3.  Two carbohydrate binding sites in the H(CC)-domain of tetanus neurotoxin are required for toxicity.

Authors:  Andreas Rummel; Steffen Bade; Jürgen Alves; Hans Bigalke; Thomas Binz
Journal:  J Mol Biol       Date:  2003-02-21       Impact factor: 5.469

4.  Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes.

Authors:  Michael R Baldwin; Joseph T Barbieri
Journal:  Biochemistry       Date:  2007-02-21       Impact factor: 3.162

5.  Structural analysis of botulinum neurotoxin type E catalytic domain and its mutant Glu212-->Gln reveals the pivotal role of the Glu212 carboxylate in the catalytic pathway.

Authors:  Rakhi Agarwal; Subramaniam Eswaramoorthy; Desigan Kumaran; Thomas Binz; Subramanyam Swaminathan
Journal:  Biochemistry       Date:  2004-06-01       Impact factor: 3.162

6.  Structure and enzymatic activity of botulinum neurotoxins.

Authors:  Subramanyam Swaminathan; Subramanian Eswaramoorthy; Desigan Kumaran
Journal:  Mov Disord       Date:  2004-03       Impact factor: 10.338

7.  Tetanus toxin fragment C binds to a protein present in neuronal cell lines and motoneurons.

Authors:  J Herreros; G Lalli; C Montecucco; G Schiavo
Journal:  J Neurochem       Date:  2000-05       Impact factor: 5.372

8.  Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway.

Authors:  Katrin Deinhardt; Sara Salinas; Carole Verastegui; Rose Watson; Daniel Worth; Sarah Hanrahan; Cecilia Bucci; Giampietro Schiavo
Journal:  Neuron       Date:  2006-10-19       Impact factor: 17.173

9.  Structural determinants of the specificity for synaptic vesicle-associated membrane protein/synaptobrevin of tetanus and botulinum type B and G neurotoxins.

Authors:  R Pellizzari; O Rossetto; L Lozzi; S Giovedi'; E Johnson; C C Shone; C Montecucco
Journal:  J Biol Chem       Date:  1996-08-23       Impact factor: 5.157

10.  Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves.

Authors:  J D Black; J O Dolly
Journal:  J Cell Biol       Date:  1986-08       Impact factor: 10.539

View more
  35 in total

Review 1.  The blockade of the neurotransmitter release apparatus by botulinum neurotoxins.

Authors:  Sergio Pantano; Cesare Montecucco
Journal:  Cell Mol Life Sci       Date:  2013-06-11       Impact factor: 9.261

Review 2.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

3.  Structural insight into exosite binding and discovery of novel exosite inhibitors of botulinum neurotoxin serotype A through in silico screening.

Authors:  Xin Hu; Patricia M Legler; Noel Southall; David J Maloney; Anton Simeonov; Ajit Jadhav
Journal:  J Comput Aided Mol Des       Date:  2014-06-24       Impact factor: 3.686

Review 4.  Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.

Authors:  Marco Pirazzini; Ornella Rossetto; Roberto Eleopra; Cesare Montecucco
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

Review 5.  Lipid-mediated endocytosis.

Authors:  Helge Ewers; Ari Helenius
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-08-01       Impact factor: 10.005

6.  A cross-over inhibitor of the botulinum neurotoxin light chain B: a natural product implicating an exosite mechanism of action.

Authors:  Nicholas T Salzameda; Lisa M Eubanks; Joseph S Zakhari; Kyoji Tsuchikama; Nicholas J DeNunzio; Karen N Allen; Mark S Hixon; Kim D Janda
Journal:  Chem Commun (Camb)       Date:  2011-01-04       Impact factor: 6.222

7.  Botulinum Neurotoxins: Mechanism of Action.

Authors:  O Rossetto; M Pirazzini; F Fabris; C Montecucco
Journal:  Handb Exp Pharmacol       Date:  2021

Review 8.  Cargo-delivery platforms for targeted delivery of inhibitor cargos against botulism.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

Review 9.  Interaction of membrane/lipid rafts with the cytoskeleton: impact on signaling and function: membrane/lipid rafts, mediators of cytoskeletal arrangement and cell signaling.

Authors:  Brian P Head; Hemal H Patel; Paul A Insel
Journal:  Biochim Biophys Acta       Date:  2013-07-27

10.  Effects of enzymatically inactive recombinant botulinum neurotoxin type A at the mouse neuromuscular junctions.

Authors:  Padmamalini Baskaran; Teresa E Lehmann; Elena Topchiy; Nagarajan Thirunavukkarasu; Shuowei Cai; Bal Ram Singh; Sharad Deshpande; Baskaran Thyagarajan
Journal:  Toxicon       Date:  2013-06-25       Impact factor: 3.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.